Alectinib supplier & exporter
Product Description
API name | Alectinib |
CAS Number | 1256580-46-7 |
Therapeutic Category | Anticancer, Antineoplastic |
Route of Administration | Capsule |
Regulatory Documents | TECH PACK, DMF |
Trader & Wholesaler of Alectinib
Mechanism of Action:
Alectinib is a second generation oral drug that selectively inhibits the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase. It is specifically used in the treatment of non-small cell lung cancer (NSCLC) expressing the ALK-EML4 (echinoderm microtubule-associated protein-like 4) fusion protein that causes proliferation of NSCLC cells.
Drug Indications:
Alectinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib